Koven Andrew I
SEC-identified person · CIK 1258673 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Neurobo Pharmaceuticals, Inc. NRBO | Director | filed 2021 - 2026 |
| Kala Pharmaceuticals, Inc. KALA | Director | filed 2017 - 2025 |
| Aralez Pharmaceuticals Inc. ARLZ | President & Chief Business Off | filed 2016 - 2018 |
| Pozen INC /NC POZN | President, Chief Business Ofc. | filed 2015 - 2015 |
| Auxilium Pharmaceuticals INC AUXL | EVP, CAO, GC and Secretary | filed 2012 - 2015 |
| Neurologix INC/DE NRGX:OB | Director · See Remarks | filed 2011 - 2011 |
| Inspire Pharmaceuticals INC ISPH | EVP & Chief Admin & Legal Ofc | filed 2010 - 2011 |
| Sepracor INC /DE/ SEPR | Exec. VP, General Counsel | filed 2007 - 2009 |
| KOS Pharmaceuticals INC kosp | EVP, General Counsel | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.